Banque Pictet & Cie SA lifted its position in Colgate-Palmolive (NYSE:CL) by 13.2% during the third quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 1,482,630 shares of the company’s stock after buying an additional 172,500 shares during the period. Colgate-Palmolive makes up 2.4% of Banque Pictet & Cie SA’s holdings, making the stock its 10th largest position. Banque Pictet & Cie SA owned about 0.17% of Colgate-Palmolive worth $108,010,000 at the end of the most recent quarter.
Other institutional investors and hedge funds have also recently bought and sold shares of the company. Renaissance Technologies LLC grew its holdings in shares of Colgate-Palmolive by 42.4% in the 2nd quarter. Renaissance Technologies LLC now owns 9,753,400 shares of the company’s stock worth $723,020,000 after acquiring an additional 2,903,800 shares during the last quarter. APG Asset Management N.V. grew its holdings in shares of Colgate-Palmolive by 243.0% in the 3rd quarter. APG Asset Management N.V. now owns 4,070,784 shares of the company’s stock worth $296,557,000 after acquiring an additional 2,884,100 shares during the last quarter. First Eagle Investment Management LLC grew its holdings in shares of Colgate-Palmolive by 35.8% in the 3rd quarter. First Eagle Investment Management LLC now owns 6,641,548 shares of the company’s stock worth $483,837,000 after acquiring an additional 1,750,417 shares during the last quarter. Vanguard Group Inc. grew its holdings in shares of Colgate-Palmolive by 2.4% in the 2nd quarter. Vanguard Group Inc. now owns 67,875,384 shares of the company’s stock worth $5,031,602,000 after acquiring an additional 1,621,392 shares during the last quarter. Finally, Swedbank acquired a new position in shares of Colgate-Palmolive in the 3rd quarter worth $102,014,000. 72.83% of the stock is currently owned by institutional investors.
In other Colgate-Palmolive news, Director Stephen I. Sadove sold 20,780 shares of the business’s stock in a transaction dated Monday, November 6th. The stock was sold at an average price of $70.52, for a total value of $1,465,405.60. Following the transaction, the director now owns 36,268 shares in the company, valued at $2,557,619.36. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Victoria L. Dolan sold 9,000 shares of the business’s stock in a transaction dated Tuesday, November 14th. The shares were sold at an average price of $73.41, for a total value of $660,690.00. The disclosure for this sale can be found here. Insiders sold 181,048 shares of company stock worth $13,168,995 in the last 90 days. Corporate insiders own 1.02% of the company’s stock.
Colgate-Palmolive (CL) opened at $75.33 on Friday. Colgate-Palmolive has a twelve month low of $63.43 and a twelve month high of $77.27. The company has a current ratio of 1.23, a quick ratio of 0.92 and a debt-to-equity ratio of 24.42. The firm has a market capitalization of $65,726.17, a price-to-earnings ratio of 29.09, a PEG ratio of 3.19 and a beta of 0.80.
Colgate-Palmolive (NYSE:CL) last issued its quarterly earnings results on Friday, October 27th. The company reported $0.73 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.73. Colgate-Palmolive had a return on equity of 2,782.56% and a net margin of 15.10%. The business had revenue of $3.97 billion for the quarter, compared to the consensus estimate of $3.94 billion. During the same quarter in the previous year, the company posted $0.73 earnings per share. Colgate-Palmolive’s revenue for the quarter was up 2.8% compared to the same quarter last year. analysts expect that Colgate-Palmolive will post 2.88 EPS for the current fiscal year.
Colgate-Palmolive Company Profile
Colgate-Palmolive Company (Colgate) is a consumer products company. The Company operates in two product segments: Oral, Personal and Home Care, and Pet Nutrition. The Oral, Personal and Home Care product segment is operated through five geographic segments, which include North America, Latin America, Europe, Asia Pacific and Africa/Eurasia.
Want to see what other hedge funds are holding CL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Colgate-Palmolive (NYSE:CL).
Receive News & Ratings for Colgate-Palmolive Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Colgate-Palmolive and related companies with MarketBeat.com's FREE daily email newsletter.